Publish in this journal
Journal Information
Vol. 70. Issue 1.
Pages 53 (January 2017)
Share
Share
Download PDF
More article options
Vol. 70. Issue 1.
Pages 53 (January 2017)
Image in cardiology
DOI: 10.1016/j.rec.2016.04.004
Full text access
Ultrasound-accelerated Thrombolysis in a Sub-massive Pulmonary Embolism
Trombolisis acelerada por ultrasonidos en una embolia pulmonar submasiva
Visits
3372
Ramón Rodríguez-Olivares⿿
Corresponding author
ramoncadiz@gmail.com

Corresponding author:
, Adriaan O. Kraaijeveld, Pieter R. Stella
Department of Interventional Cardiology, Utrecht Medical Center, Utrecht, The Netherlands
This item has received
3372
Visits
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

A 92-year-old woman with no medical history of note was admitted to the emergency room with sudden shortness of breath. She had tachycardia around 110 bpm, with blood pressure of 90/60mmHg and an SpO2 of 81% without oxygen support. Massive pulmonary embolism was suspected and computed tomography was immediately performed showing a bilateral submassive pulmonary embolism (Figures A and B, arrows). The performance of systemic thrombolysis was proposed, but due to the patient's advanced age and a nonnegligible risk of major bleeding, it was finally decided to perform a catheter-directed thrombolysis by using an ekosonic ultrasound-accelerated thrombolysis system (EKOS, Bothell, Washington, United States), a novel catheter-based technique that allows local low-dose thrombolysis due to an enhanced effect triggered by ultrasounds and therefore a decreased risk of major bleeding.

(0.16MB).

The EKOS system comprises 2 components: an EkoSonic control unit and a catheter with ultrasonic microtransducer core (Figure C). The baseline pulmonary angiogram showed a large amount of thrombus distributed at both the right and left main pulmonary branches (Figure D, asterisks), with poor flow toward segmental branches and poor runoff of contrast. Subsequently, the catheters were placed at both pulmonary arteries (Figure E).

A regimen of tissue-plasminogen activator (Genentech, South San Francisco, California, United States) was started at 1mg/catheter/h for 12hours, with a total dose of 24mg.

Twenty-four hours later a follow-up angiogram was performed showing almost complete resolution of the thrombus with good arborization of the segmental branches (Figure F) and no bleeding reported during hospitalization.

Copyright © 2016. Sociedad Española de Cardiología
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.